Estimating Indirect and OOP Costs in Pediatric Inflammatory Bowel Disease: a National Study

Summary

inflammation of the gastrointestinal tract. A recent Canadian study from found that Canada has amongst highest incidence rates of childhood-onset IBD (10 per 100,000 for children \<16y). In 2012, Crohn's and Colitis Canada estimated that direct medical costs of IBD in Canada were \>$1 billion, and estimated indirect costs amounting to $1.8 billion. An American study demonstrated the direct costs of caring for children with IBD was double those for adults. Indirect health care costs in children with IBD have not been well-described. The Canadian Gastro-Intestinal Epidemiology Consortium (CanGIEC) is a pan-Canadian network of new and established IBD clinician-researchers and methodologists from 6 provinces experienced in the use of health administrative data. CanGIEC is evaluating variation in care of children with IBD, and will expand this research stream to assess direct and indirect cost of care. This will involve a collaboration with the CIHR/CHILD Foundation Canadian Children IBD Network (CIDsCaNN), which comprises an inception cohort of children diagnosed at all 12 pediatric IBD centres across Canada.

Hypothesis: Direct health costs are dominated by medication expenses (particularly biologics), with resulting variation within and across provinces in costs and out-of-pocket expenses to the families due to coverage disparity. Indirect costs include school and parental absenteeism, and productivity losses.

Aims:

1. Determine the cost of care of children with IBD, incurred by caregivers,across Canada. Costs include:

a Indirect costs - costs to the patient or family related to having the disease but not to direct health care.

b. Out of pocket (OOP) - costs paid in cash or credit for health-related expenses not covered by the public health or private insurance systems.
2. Determine the sociodemographic and disease characteristics associated with higher costs

Methods:

Population: Incident cases of IBD (\<16y) over 12 months (est. enrollment 250-300).

Indirect and OOP disease-related costs will be determined with surveys conducted one year following diagnosis and every 6mo for 2y. These will be conducted querying families on the preceding 4 weeks including: school and work days missed, out-of-pocket expenses, distance travelled to appointments, medications expenses incurred, and disability benefits collected. Indirect costs will be calculated using the Human Capital Approach (gross income not earned due to disease).

Conditions

• IBD

Interventions

OTHER

Non-interventional study

Non-interventional study

Sponsors & Collaborators

• University of Ottawa

  collaborator OTHER

• University of Toronto

  collaborator OTHER

• University of Alberta

  collaborator OTHER

• University of Calgary

  collaborator OTHER

• Dalhousie University

  collaborator OTHER

• Provincial Health Services Authority

  collaborator OTHER

• University of Manitoba

  lead OTHER

Principal Investigators

• WAEL EL-MATARY, MD · Associate Professor, Section Head, Pediatric Gastroenterology

Eligibility

Max Age

17 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2017-11-01

Primary Completion

2019-11-07

Completion

2020-05-01

Countries

• Canada

Study Locations